Effect of porcine gastric inhibitory polypeptide on β-cell function in type I and type II diabetes mellitus

Pfeifer, 1981, Insulin secretion in diabetes mellitus, Am J Med, 70, 579, 10.1016/0002-9343(81)90579-9 Krarup, 1983, Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed Type 1 (insulin-dependent) diabetics, J Clin Endocrinol Metab, 56, 1306, 10.1210/jcem-56-6-1306 Ganda, 1984, Differential sensitivity to β-cell secretagogues in “early,” Type 1 diabetes mellitus, Diabetes, 33, 516, 10.2337/diab.33.6.516 Creutzfeldt, 1979, The incretin concept today, Diabetologia, 16, 75, 10.1007/BF01225454 Schäfer, 1979, Stimulation of (pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas, Acta Endocrinol, 91, 493, 10.1530/acta.0.0910493 Moody, 1980, The effects of GIP and glucagon on the synthesis and release of IRI by cultured rat pancreatic cells, Regul Pept, 1, 76, 10.1016/0167-0115(80)90171-8 Elahi, 1979, Pancreatic α- and β-cell responses to GIP infusion in normal man, Am J Physiol, 237, E185 Ross, 1974, Effects of gastric inhibitory polypeptide on endocrine pancreas in normal and diabetic subjects, Diabetologia, 10, 384 Brown, 1975, Identification and actions of gastric inhibitory polypeptide, Recent Prog Horm Res, 31, 487 Amland, 1985, Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state, Scand J Gastroenterol, 20, 315, 10.3109/00365528509091657 Jones, 1985, The metabolic effects of porcine GIP infused at physiological concentrations in normal subjects and newly diagnosed diabetics (NIDDS), Diabetes Res Clin Pract, 1, S274 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, 1039, 10.2337/diab.28.12.1039 Madsbad, 1979, Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes, Br Med J, 2, 1257, 10.1136/bmj.2.6200.1257 Moody, 1981, Structure-function relationships in porcine GIP, Diabetologia, 21, 306 Wolfbrandt, 1986, The effects of porcine GIP on insulin secretion and glucose clearance in the pig, Horm Metab Res, 18, 159, 10.1055/s-2007-1012260 Faber, 1977, C-peptide response to glucagon. A test for the residual B-cell function in diabetes mellitus, Diabetes, 26, 605, 10.2337/diab.26.7.605 Hendriksen, 1977, Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon, Diabetologia, 13, 615, 10.1007/BF01236316 Kühl, 1986, Study of blood glucose dependency and reproducibility of the glucagon test, Diabetes, 35, 120A Krarup, 1984, The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera, Regul Pept, 9, 35, 10.1016/0167-0115(84)90005-3 Faber, 1976, Production of antisera to synthetic benzyloxy-carbonyl-C-peptide of human proinsulin, Hoppe-Seyler's Z Physiol Chem, 357, 751, 10.1515/bchm2.1976.357.1.751 Heding, 1975, Radioimmunological determination of human C-peptide in serum, Diabetologia, 11, 541, 10.1007/BF01222104 Nakagawa, 1973, A simple method for the determination of serum free insulin levels in insulin-treated patients, Diabetes, 22, 590, 10.2337/diab.22.8.590 Krarup, 1985, Immunoreactive gastric inhibitory polypeptide response to a meal during the first 18 months after diagnosis of Type 1 (insulin-dependent) diabetes mellitus, J Clin Endocrinol Metab, 60, 120, 10.1210/jcem-60-1-120 Jorde, 1980, Diurnal variation of plasma gastric inhibitory polypeptide in man, Scand J Gastroenterol, 15, 617, 10.3109/00365528009182224 Salera, 1983, Circadian rhythm of gastric inhibitory polypeptide (GIP) in man, Metabolism, 32, 21, 10.1016/0026-0495(83)90150-6 Elahi, 1984, The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus, Diabetes, 33, 950, 10.2337/diab.33.10.950 Berthoud, 1984, The relative contribution of the nervous system, hormones, and metabolites to the total insulin response during a meal in the rat, Metabolism, 33, 18, 10.1016/0026-0495(84)90157-4 Holst, 1985, Neural regulation of pancreatic hormone secretion, Clin Physiol, 5, 34, 10.1111/j.1365-2281.1985.tb00007.x Dupre, 1973, Stimulation of insulin secretion by gastric inhibitory polypeptide in man, J Clin Endocrinol Metab, 37, 826, 10.1210/jcem-37-5-826 Ross, 1978, Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects, Diabetes, 27, 327, 10.2337/diab.27.3.327 De Fronzo, 1982, Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus, Diabetologia, 23, 313 Sarson, 1982, The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man, Diabetologia, 22, 33, 10.1007/BF00253866 Sarson, 1984, Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?, Diabetes, 33, 389, 10.2337/diab.33.4.389 Krarup, 1985, Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat, Am J Physiol, 249, E195 Moody, 1984, The isolation and sequencing of human gastric inhibitory polypeptide (GIP), FEBS Lett, 172, 142, 10.1016/0014-5793(84)81114-X Kühl, 1978, C-peptide metabolism and the liver, Diabetes, 27, 197, 10.2337/diab.27.1.S197 Polonsky, 1984, C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations, Diabetes, 33, 486, 10.2337/diab.33.5.486